From Bloomberg:
Sanofi-Aventis SA shares had their biggest drop in three years, wiping out more than $7 billion in market value, after a U.S. panel blocked the company’s new weight-loss pill because it was linked to suicides.
Says Derek Lowe:
Everyone will have heard the news about Wednesday’s FDA Advisory Commitee vote on Accomplia / Zimulti (rimonabant). […]
Entries Tagged as 'Sanofi-Aventis'
Zimulti: An obesity drug to die for?
June 17th, 2007 · No Comments
Tags: FDA · Pharmaceutical companies · Prescription drugs · Sanofi-Aventis · Zimulti
Generic Ambien on the way
April 30th, 2007 · No Comments
In case you were sleeping when the news was announced last week, generic versions of Ambien are on the way. As Reuters reported:
The Food and Drug Administration said … that regulators had approved generic versions of Ambien, a blockbuster sleeping pill from Sanofi-Aventis. The drug, also known as zolpidem tartrate, has been linked to […]
Tags: Ambien · Sanofi-Aventis
New “black box” warning on controversial antibiotic
February 14th, 2007 · No Comments
The FDA announced that the antibiotic Ketek, used to treat pneumonia, must come with a new “black box label” — the strongest warning the agency can impose on a drug. Additionally, Ketek can no longer be recommended for treating milder conditions such as sinusitis and bronchitis. The changes come after the medication was […]
[Read more →]
Tags: Ketek · Prescription drugs · Sanofi-Aventis
